TY - JOUR T1 - Assessing Prediction Performance of Neoadjuvant Chemotherapy Response in Bladder Cancer JF - bioRxiv DO - 10.1101/075705 SP - 075705 AU - Chris Cremer Y1 - 2016/01/01 UR - http://biorxiv.org/content/early/2016/09/16/075705.abstract N2 - Neoadjuvant chemotherapy is a treatment routinely prescribed to patients diagnosed with muscle-invasive bladder cancer. Unfortunately, not all patients are responsive to this treatment and would greatly benefit from an accurate prediction of their expected response to chemotherapy. In this project, I attempt to develop a model that will predict response using tumour microarray data. I show that using my dataset, every method is insufficient at accurately classifying responders and non-responders. ER -